BioCentury
ARTICLE | Financial News

Valeant Pharmaceuticals financial update

June 17, 2013 7:00 AM UTC

Valeant filed a shelf registration covering the sale of up to $3 billion of its common stock. The company, which closed Friday at C$85.69, has 305.9 million shares outstanding. ...